Savara is really a scientific-stage biopharmaceutical company producing treatment options for rare respiratory disorders. Its guide item applicant is an immunostimulator called molgramostim. Molgramostim is in stage 3 medical trials to treat autoimmune pulmonary alveolar proteinosis, or aPAP.Penny stocks are low-priced and sometimes sketchy, but th